Stockreport

Werewolf Therapeutics Announces Plan to Explore Strategic Alternatives

Werewolf Therapeutics, Inc.  (HOWL) 
PDF WATERTOWN, Mass., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (Nasdaq: HOWL) (the “Company” or “Werewolf”), an innovative biopharmaceutical company p [Read more]